Nampt/PBEF/visfatin and cancer

Cancer Biology & Therapy
Tie-qiang Bi, Xiang-ming Che

Abstract

Nampt/PBEF/visfatin is the rate-limiting enzyme that catalyzes the first step in NAD biosynthesis from nicotinamide and regulates growth, apoptosis and angiogenesis of mammalian cells. This enzyme was originally cloned as a putative cytokine shown to enhance the B cell precursor maturation in the presence of IL-7 and stem cell factor. A number of cancers have increased expression of Nampt/PBEF/visfatin, which regulates a variety of different signaling pathways such as PI3K/Akt, ERK1/2 and STAT3. FK866/APO866 and CHS828/GMX1777 are two known inhibitors of Nampt/PBEF/visfatin and have been evaluated as anticancer agents in the clinic. This review will focus on its role in carcinogenesis and cancer progression and its inhibitors as therapeutic target for cancer treatment.

Citations

Dec 12, 2012·Medicina oral, patología oral y cirugía bucal·Tsai Yu-DuanHoung Jer-Yiing
Dec 24, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kui ZhangLin Zhang
Aug 26, 2014·Pharmacological Reports : PR·Grzegorz SłomianPrzemysław Nowak
Mar 31, 2015·Molecular Medicine Reports·Wei ZhaoXiang-Ming Che
Feb 14, 2013·Medical Hypotheses·Daxing XieJianping Gong
Jul 20, 2012·Thrombosis Research·Bente HalvorsenPål Aukrust
Sep 29, 2011·Neuroscience Letters·Young-Soon KangSoo-Kyung Bae
Feb 26, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·B CabiaA B Crujeiras
Feb 8, 2013·Diabetes/metabolism Research and Reviews·P MatafomeR Seiça
Nov 30, 2010·Biochimica Et Biophysica Acta·Pedro L Prieto-HontoriaMaría J Moreno-Aliaga
May 8, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nadia Sawicka-GutajMarek Ruchała
Nov 21, 2015·Cell Death and Differentiation·T SharifP W K Lee
Jan 25, 2012·International Journal of Inflammation·Andreas HillenbrandMarkus Huber-Lang
Jul 23, 2013·Cancer Treatment Reviews·E NtikoudiK N Syrigos
Mar 12, 2013·Cytokine·Mohammad Sadegh FazeliIraj Nabipour
Feb 12, 2013·Molecular Cell·Joshua L Andersen, Sally Kornbluth
Feb 7, 2015·Biochemical and Biophysical Research Communications·Susanne SchusterAntje Garten
May 16, 2014·Frontiers in Endocrinology·Ana I Pérez-HernándezGema Frühbeck
Apr 30, 2016·British Journal of Pharmacology·Ambra A GrollaJaswinder K Sethi
May 18, 2016·Expert Review of Anticancer Therapy·Hang ChenCanhua Huang
May 26, 2016·Basic & Clinical Pharmacology & Toxicology·Guanghai WangYu Li
Aug 20, 2016·Journal of Medicinal Chemistry·Mark ZakPeter S Dragovich
Jan 18, 2018·Antioxidants & Redox Signaling·Tanveer SharifShashi Gujar
Nov 25, 2018·Journal of Cellular Physiology·Masoumeh MohammadiHassan Mehrad-Majd
Feb 1, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Zhongmin WangLiping Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.